{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T14:17:14Z","timestamp":1788358634171,"version":"build-2803163510"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100007957","name":"Chongqing Municipal Education Commission","doi-asserted-by":"publisher","award":["KJZD-K202500405"],"award-info":[{"award-number":["KJZD-K202500405"]}],"id":[{"id":"10.13039\/501100007957","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012669","name":"Natural Science Foundation Project of Chongqing","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012669","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005230","name":"Natural Science Foundation of Chongqing Municipality","doi-asserted-by":"publisher","award":["CSTB2024NSCQ-MSX0169"],"award-info":[{"award-number":["CSTB2024NSCQ-MSX0169"]}],"id":[{"id":"10.13039\/501100005230","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004374","name":"Chongqing Medical University","doi-asserted-by":"publisher","award":["W0177"],"award-info":[{"award-number":["W0177"]}],"id":[{"id":"10.13039\/501100004374","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Virology"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.jcv.2026.105921","type":"journal-article","created":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T16:19:22Z","timestamp":1769271562000},"page":"105921","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["A machine learning model for predicting complete virological response in chronic hepatitis B patients receiving first-line nucleos(t)ide analogues therapy"],"prefix":"10.1016","volume":"183","author":[{"given":"Xiaoqin","family":"Yuan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyi","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongqian","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wencen","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JinJing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhili","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiying","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6523-9747","authenticated-orcid":false,"given":"Li","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.jcv.2026.105921_bib1","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/S2468-1253(23)00197-8","article-title":"Global prevalence, cascade of care, and prophylaxis coverage of hepatitis B in 2022: a modelling study","volume":"8","author":"Collaborators","year":"2023","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"10.1016\/j.jcv.2026.105921_bib2","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.coviro.2016.06.004","article-title":"Current treatments for chronic hepatitis B virus infections","volume":"18","author":"Zoulim","year":"2016","journal-title":"Curr. Opin. Virol."},{"key":"10.1016\/j.jcv.2026.105921_bib3","article-title":"AASLD\/IDSA Practice Guideline on treatment of chronic hepatitis B","author":"Ghany","year":"2025","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.jcv.2026.105921_bib4","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.jhep.2025.03.018","article-title":"Clinical practice guidelines on the management of hepatitis B virus infection","volume":"83","author":"EASL","year":"2025","journal-title":"J. Hepatol."},{"key":"10.1016\/j.jcv.2026.105921_bib5","article-title":"Risk factors related to low-level viraemia in chronic hepatitis B patients receiving entecavir treatment","volume":"14","author":"Li","year":"2024","journal-title":"Front. Cell. Infect. Microbiol."},{"issue":"23","key":"10.1016\/j.jcv.2026.105921_bib6","doi-asserted-by":"crossref","first-page":"2810","DOI":"10.1097\/CM9.0000000000001793","article-title":"Low-level viremia in nucleoside analog-treated chronic hepatitis B patients","volume":"134","author":"Zhang","year":"2021","journal-title":"Chin. Med. J."},{"issue":"8","key":"10.1016\/j.jcv.2026.105921_bib7","doi-asserted-by":"crossref","first-page":"666","DOI":"10.3748\/wjg.v27.i8.666","article-title":"New therapeutic options for persistent low-level viremia in patients with chronic hepatitis B virus infection: Increase of entecavir dosage","volume":"27","author":"Yin","year":"2021","journal-title":"World J. Gastroenterol."},{"issue":"1","key":"10.1016\/j.jcv.2026.105921_bib8","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1001\/jamaoncol.2018.4070","article-title":"Risk of hepatocellular carcinoma in patients treated with entecavir vs tenofovir for chronic hepatitis B: A Korean nationwide cohort study","volume":"5","author":"Choi","year":"2019","journal-title":"JAMA Oncol."},{"issue":"7","key":"10.1016\/j.jcv.2026.105921_bib9","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1136\/gutjnl-2019-318947","article-title":"Comparison of tenofovir and entecavir on the risk of hepatocellular carcinoma and mortality in treatment-na\u00efve patients with chronic hepatitis B in Korea: a large-scale, propensity score analysis","volume":"69","author":"Lee","year":"2020","journal-title":"Gut"},{"key":"10.1016\/j.jcv.2026.105921_bib10","doi-asserted-by":"crossref","first-page":"2751","DOI":"10.2147\/IDR.S463843","article-title":"Non-invasive monitoring of the impact of low-level viremia on liver fibrosis in treated chronic hepatitis B patients","volume":"17","author":"Xu","year":"2024","journal-title":"Infect. Drug Resist."},{"issue":"6","key":"10.1016\/j.jcv.2026.105921_bib11","first-page":"850","article-title":"Chronic hepatitis B infection with low level viremia correlates with the progression of the liver disease","volume":"9","author":"Zhang","year":"2021","journal-title":"J. Clin. Transl. Hepatol."},{"issue":"11","key":"10.1016\/j.jcv.2026.105921_bib12","doi-asserted-by":"crossref","DOI":"10.4254\/wjh.v16.i11.1321","article-title":"Low level of hepatitis B viremia is associated with increased risk of hepatocellular carcinoma in compensated cirrhotic patients","volume":"16","author":"Lin","year":"2024","journal-title":"World J. Hepatol."},{"issue":"9","key":"10.1016\/j.jcv.2026.105921_bib13","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.7150\/ijms.95861","article-title":"Risk factors and nomogram model for hepatocellular carcinoma development in chronic hepatitis B patients with low-level viremia","volume":"21","author":"Chen","year":"2024","journal-title":"Int. J. Med. Sci."},{"issue":"5","key":"10.1016\/j.jcv.2026.105921_bib14","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1111\/jvh.12838","article-title":"Delayed viral suppression during antiviral therapy is associated with increased hepatocellular carcinoma rates in HBeAg-positive high viral load chronic hepatitis B","volume":"25","author":"Nam","year":"2018","journal-title":"J. Viral Hepat."},{"issue":"1","key":"10.1016\/j.jcv.2026.105921_bib15","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/s12933-025-02615-w","article-title":"Predicting major adverse cardiac events in diabetes and chronic kidney disease: a machine learning study from the Silesia Diabetes-Heart Project","volume":"24","author":"Kwiendacz","year":"2025","journal-title":"Cardiovasc Diabetol."},{"key":"10.1016\/j.jcv.2026.105921_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijmedinf.2024.105660","article-title":"Machine learning models to further identify advantaged populations that can achieve functional cure of chronic hepatitis B virus infection after receiving Peg-IFN alpha treatment","volume":"193","author":"Zhong","year":"2025","journal-title":"Int J. Med Inf."},{"issue":"1","key":"10.1016\/j.jcv.2026.105921_bib17","doi-asserted-by":"crossref","DOI":"10.1080\/22221751.2025.2498572","article-title":"A machine learning model for mortality prediction in patients with severe fever with thrombocytopenia syndrome: a prospective, multicenter cohort study","volume":"14","author":"Liu","year":"2025","journal-title":"Emerg. Microbes Infect."},{"key":"10.1016\/j.jcv.2026.105921_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiomed.2023.107555","article-title":"The enlightening role of explainable artificial intelligence in medical & healthcare domains: a systematic literature review","volume":"166","author":"Ali","year":"2023","journal-title":"Comput. Biol. Med"},{"issue":"6","key":"10.1016\/j.jcv.2026.105921_bib19","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1002\/hep.21178","article-title":"Development of a simple noninvasive index to predict significant fibrosis in patients with HIV\/HCV coinfection","volume":"43","author":"Sterling","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.jcv.2026.105921_bib20","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.jchromb.2012.05.020","article-title":"A support vector machine-recursive feature elimination feature selection method based on artificial contrast variables and mutual information","volume":"910","author":"Lin","year":"2012","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci."},{"issue":"2","key":"10.1016\/j.jcv.2026.105921_bib21","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1093\/bib\/bbx124","article-title":"Evaluation of variable selection methods for random forests and omics data sets","volume":"20","author":"Degenhardt","year":"2019","journal-title":"Brief. Bioinform"},{"key":"10.1016\/j.jcv.2026.105921_bib22","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.jbi.2015.11.012","article-title":"Stabilizing l1-norm prediction models by supervised feature grouping","volume":"59","author":"Kamkar","year":"2016","journal-title":"J. Biomed. Inf."},{"issue":"1","key":"10.1016\/j.jcv.2026.105921_bib23","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1097\/EDE.0b013e3181c30fb2","article-title":"Assessing the performance of prediction models: a framework for traditional and novel measures","volume":"21","author":"Steyerberg","year":"2010","journal-title":"Epidemiology"},{"issue":"10","key":"10.1016\/j.jcv.2026.105921_bib24","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1016\/j.jclinepi.2007.06.001","article-title":"The K-nearest neighbor algorithm predicted rehabilitation potential better than current Clinical Assessment Protocol","volume":"60","author":"Zhu","year":"2007","journal-title":"J. Clin. Epidemiol."},{"issue":"12","key":"10.1016\/j.jcv.2026.105921_bib25","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1038\/nbt1206-1565","article-title":"What is a support vector machine?","volume":"24","author":"Noble","year":"2006","journal-title":"Nat. Biotechnol."},{"issue":"1","key":"10.1016\/j.jcv.2026.105921_bib26","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1186\/s12874-023-01965-x","article-title":"Use and misuse of random forest variable importance metrics in medicine: demonstrations through incident stroke prediction","volume":"23","author":"Wallace","year":"2023","journal-title":"BMC Med Res Method."},{"issue":"5","key":"10.1016\/j.jcv.2026.105921_bib27","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1023\/A:1016409317640","article-title":"Decision trees: an overview and their use in medicine","volume":"26","author":"Podgorelec","year":"2002","journal-title":"J. Med Syst."},{"key":"10.1016\/j.jcv.2026.105921_bib28","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3389\/fnbot.2013.00021","article-title":"Gradient boosting machines, a tutorial","volume":"7","author":"Natekin","year":"2013","journal-title":"Front Neurorobot"},{"issue":"2","key":"10.1016\/j.jcv.2026.105921_bib29","doi-asserted-by":"crossref","first-page":"111","DOI":"10.2174\/1573409914666180525124608","article-title":"The Application of Machine Learning Techniques in Clinical Drug Therapy","volume":"15","author":"Meng","year":"2019","journal-title":"Curr. Comput. Aided Drug Des."},{"key":"10.1016\/j.jcv.2026.105921_bib30","article-title":"Toronto HCC risk index: A validated scoring system to predict 10-year risk of HCC in patients with cirrhosis","author":"Sharma","year":"2017","journal-title":"J. Hepatol."},{"issue":"3","key":"10.1016\/j.jcv.2026.105921_bib31","doi-asserted-by":"crossref","DOI":"10.1002\/jmv.70302","article-title":"Application of Interpretable Machine Learning Models to Predict the Risk Factors of HBV-Related Liver Cirrhosis in CHB Patients Based on Routine Clinical Data: A Retrospective Cohort Study","volume":"97","author":"Xia","year":"2025","journal-title":"J. Med Virol."},{"issue":"4","key":"10.1016\/j.jcv.2026.105921_bib32","doi-asserted-by":"crossref","first-page":"802","DOI":"10.3904\/kjim.2019.037","article-title":"Efficacy of long-term tenofovir disoproxil fumarate therapy in chronic hepatitis B patients with partial virologic response in real practice","volume":"34","author":"Song","year":"2019","journal-title":"Korean J. Intern Med"},{"issue":"34","key":"10.1016\/j.jcv.2026.105921_bib33","doi-asserted-by":"crossref","first-page":"8139","DOI":"10.12998\/wjcc.v11.i34.8139","article-title":"Efficacy and safety of tenofovir alafenamide in patients with chronic hepatitis B exhibiting suboptimal response to entecavir","volume":"11","author":"Yuan","year":"2023","journal-title":"World J. Clin. Cases"},{"issue":"8","key":"10.1016\/j.jcv.2026.105921_bib34","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1002\/jgh3.12950","article-title":"Switching from entecavir to tenofovir alafenamide for maintaining complete virological response in chronic hepatitis B","volume":"7","author":"Ishido","year":"2023","journal-title":"JGH Open"},{"key":"10.1016\/j.jcv.2026.105921_bib35","article-title":"Adding pegylated interferon-\u03b1 to nucleos(t)ide analogs improves HBsAg clearance in chronic hepatitis B with low-level viremia","volume":"12","author":"Wang","year":"2025","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.jcv.2026.105921_bib36","article-title":"Serum cytokine change profile associated with HBsAg loss during combination therapy with PEG-IFN-\u03b1 in NAs-suppressed chronic hepatitis B patients","volume":"14","author":"Wang","year":"2023","journal-title":"Front Immunol."}],"container-title":["Journal of Clinical Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1386653226000107?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1386653226000107?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T19:07:06Z","timestamp":1778612826000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1386653226000107"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":36,"alternative-id":["S1386653226000107"],"URL":"https:\/\/doi.org\/10.1016\/j.jcv.2026.105921","relation":{},"ISSN":["1386-6532"],"issn-type":[{"value":"1386-6532","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A machine learning model for predicting complete virological response in chronic hepatitis B patients receiving first-line nucleos(t)ide analogues therapy","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Virology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcv.2026.105921","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"105921"}}